Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 3.850
0.00 (0.00%)
Aug 6, 2026, 12:18 PM AEST
Vitrafy Life Sciences Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Vitrafy Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $4.61. The average 1-year stock price forecast is 19.74% higher than the current stock price, while the lowest is $4.12 (+7.01%) and the highest is $5.10 (+32.47%).
Price Target: $4.61 (+19.74%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vitrafy Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bell Potter | Bell Potter | Buy Maintains $5.15 | Buy | Maintains | $5.15 | +33.77% | Aug 5, 2026 |
| Ord Minnett | Ord Minnett | Buy Maintains $4.20 | Buy | Maintains | $4.20 | +9.09% | Jul 3, 2026 |
Financial Forecast
Revenue This Year
1.91M
from 1.05M
Increased by 82.72%
Revenue Next Year
7.14M
from 1.91M
Increased by 273.06%
EPS This Year
-0.25
from -0.73
EPS Next Year
-0.23
from -0.25
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.